Laboratory capability and surveillance testing for Middle East respiratory syndrome coronavirus infection in the WHO European Region, June 2013.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationEuro Surveill. June 2013. 2014, 19 (40):20923
AbstractSince September 2012, over 90 cases of respiratory disease caused by a novel coronavirus, now named Middle East respiratory syndrome coronavirus (MERSCoV), have been reported in the Middle East and Europe. To ascertain the capabilities and testing experience of national reference laboratories across the World Health Organization (WHO) European Region to detect this virus, the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe conducted a joint survey in November 2012 and a follow-up survey in June 2013. In 2013, 29 of 52 responding WHO European Region countries and 24 of 31 countries of the European Union/European Economic Area (EU/EEA) had laboratory capabilities to detect and confirm MERS-CoV cases, compared with 22 of 46 and 18 of 30 countries, respectively, in 2012. By June 2013, more than 2,300 patients had been tested in 23 countries in the WHO European Region with nine laboratory-confirmed MERS-CoV cases. These data indicate that the Region has developed significant capability to detect this emerging virus in accordance with WHO and ECDC guidance. However, not all countries had developed capabilities, and the needs to do so should be addressed. This includes enhancing collaborations between countries to ensure diagnostic capabilities for surveillance of MERS-CoV infections across the European Region.
DescriptionTo access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files. This article is open access.
RightsArchived with thanks to Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin
- Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012.
- Authors: Palm D, Pereyaslov D, Vaz J, Broberg E, Zeller H, Gross D, Brown CS, Struelens MJ, Joint ECDC-WHO Regional Office for Europe Novel Coronavirus Laboratory Survey participants., ECDC National Microbiology Focal Points., WHO European Region EuroFlu Network., European Network for Diagnostics of "Imported" Viral Diseases (ENIVD).
- Issue date: 2012 Dec 6
- Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020.
- Authors: Reusken CBEM, Broberg EK, Haagmans B, Meijer A, Corman VM, Papa A, Charrel R, Drosten C, Koopmans M, Leitmeyer K, On Behalf Of Evd-LabNet And Erli-Net
- Issue date: 2020 Feb
- Korean Society for Laboratory Medicine Practice Guidelines for the Molecular Diagnosis of Middle East Respiratory Syndrome During an Outbreak in Korea in 2015.
- Authors: Ki CS, Lee H, Sung H, Kim S, Seong MW, Yong D, Kim JS, Lee MK, Kim MN, Choi JR, Kim JH, Korean Society for Laboratory Medicine MERS-CoV Laboratory Response Task Force.
- Issue date: 2016 May
- Proficiency testing for the detection of Middle East respiratory syndrome coronavirus demonstrates global capacity to detect Middle East respiratory syndrome coronavirus.
- Authors: Theis T, Lau KA, Gray JL, Oxenford CJ, Walker GJ, Rawlinson WD
- Issue date: 2018 Dec
- Survey of Clinical Laboratory Practices for 2015 Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea.
- Authors: Lee MK, Kim S, Kim MN, Kweon OJ, Lim YK, Ki CS, Kim JS, Seong MW, Sung H, Yong D, Lee H, Choi JR, Kim JH, MERS-CoV Laboratory Response Task Force of The Korean Society for Laboratory Medicine.
- Issue date: 2016 Mar